Q4 2019 Eloxx Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, everyone, and welcome to Eloxx Pharmaceuticals' Fourth Quarter and Full Year 2019 Earnings Webcast and Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Barbara Ryan, Eloxx' Investor Relations. Please begin.
Thank you, Gigi. Welcome and thank you for joining us this afternoon for a review of Eloxx Pharmaceuticals' fourth quarter and full year 2019 financial results and business update. Joining me this afternoon are Dr. Greg Williams, Chief Executive Officer; Neil Belloff, Chief Operating Officer and General Counsel; Tom -- Dr. Tom Haverty, our Chief Medical Officer; Dr. Matthew Goddeeris, our VP of Research; and Stephen MacDonald, our Vice President of Finance and Accounting.
Before we begin, I would like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |